Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid mesotherapy for periorbital wrinkles
IRCT20260619069876N1Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of tranexamic acid in periocular rhytides, sponsored by Shiraz University of Medical Sciences. Primary endpoints: Change in periorbital wrinkle volume, Change in clinical wrinkle severity and 3 more. Started Sep 2026; status: recruiting.
02
Drugs
tranexamic acid
03
Conditions
periocular rhytides
Beyond the preview
Go deeper on IRCT20260619069876N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260619069876N1.